Cargando…
Cardiometabolic aspects of polycystic ovarian syndrome
It is estimated that 6%–7% of women of reproductive age have polycystic ovarian syndrome (PCOS). Women with this condition exhibit an adverse cardiovascular risk profile, characteristic of the cardiometabolic syndrome and given the high prevalence of PCOS in the female population, this condition may...
Autores principales: | Cho, Li Wei, Randeva, Harpal S, Atkin, Stephen L |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1994046/ https://www.ncbi.nlm.nih.gov/pubmed/17583175 |
Ejemplares similares
-
A review of therapeutic options for managing the metabolic aspects of
polycystic ovary syndrome
por: Abdalla, Mohammed Altigani, et al.
Publicado: (2020) -
Cardiometabolic risk in polycystic ovary syndrome
por: Bajuk Studen, Katica, et al.
Publicado: (2018) -
Emerging Topics in Cardiometabolic and Psychologic Sequelae, Pathogenesis, and Treatment of Polycystic Ovarian Syndrome: A Review
por: Shah, Rachana
Publicado: (2019) -
Male Equivalent Polycystic Ovarian Syndrome: Hormonal,
Metabolic and Clinical Aspects
por: Di Guardo, Federica, et al.
Publicado: (2020) -
Metformin Treatment May Increase Omentin-1 Levels in Women With Polycystic Ovary Syndrome
por: Tan, Bee K., et al.
Publicado: (2010)